Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paul Hartmann AG | 1.98bn | 23.93m | 589.60m | 10.17k | 24.49 | 0.6546 | 5.16 | 0.2975 | 8.00 | 8.00 | 662.57 | 299.40 | 1.18 | 2.02 | 5.72 | 231,438.00 | 1.64 | 3.87 | 2.26 | 5.34 | 56.01 | 56.71 | 1.39 | 2.98 | 1.16 | 4.87 | 0.1865 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Revenio Group Oyj | 81.41m | 16.01m | 657.83m | 216.00 | 40.64 | 7.79 | 34.03 | 8.08 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| El En SpA | 582.94m | 40.62m | 685.72m | 2.11k | 16.84 | 2.35 | 13.16 | 1.18 | 0.6038 | 0.6038 | 8.67 | 4.33 | 0.9515 | 2.04 | 4.05 | 332,511.90 | 6.88 | 7.43 | 12.83 | 13.52 | 39.14 | 38.83 | 7.23 | 7.63 | 1.20 | 232.14 | 0.164 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| ChemoMetec A/S | 45.31m | 16.23m | 730.94m | 171.00 | 45.05 | 12.99 | 39.93 | 16.13 | 8.26 | 8.26 | 23.07 | 28.66 | 0.6982 | 0.8064 | 6.01 | 2,448,421.00 | 25.00 | 30.43 | 29.69 | 38.99 | 78.85 | 79.44 | 35.81 | 34.17 | 3.37 | -- | 0.0118 | 46.90 | 3.74 | 31.58 | 12.04 | 57.88 | 19.91 | -- |
| Draegerwerk AG & Co KGaA | 2.82bn | 84.61m | 732.98m | 16.48k | 8.25 | 0.579 | 3.46 | 0.26 | 5.36 | 5.36 | 178.48 | 76.35 | 1.11 | 2.61 | 4.94 | 205,046.00 | 3.39 | 3.26 | 5.03 | 4.87 | 43.32 | 44.16 | 3.06 | 3.05 | 1.17 | 5.79 | 0.1662 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
| Arjo AB (publ) | 809.71m | 38.66m | 766.69m | 6.94k | 21.25 | 1.43 | 6.87 | 0.9469 | 1.97 | 1.97 | 41.21 | 29.20 | 0.6957 | 4.40 | 6.51 | 1,651,221.00 | 3.31 | 3.55 | 4.51 | 5.55 | 43.68 | 44.01 | 4.76 | 5.41 | 0.6657 | 4.01 | 0.4123 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Medartis Holding AG | 184.24m | 537.92k | 839.10m | 829.00 | 1,456.97 | 3.45 | 44.67 | 4.55 | 0.0488 | 0.0488 | 17.33 | 20.63 | 0.6259 | 0.643 | 5.27 | 255,737.00 | 0.183 | 0.1919 | 0.2095 | 0.2153 | 79.04 | 82.33 | 0.2924 | 0.3542 | 1.59 | 1.46 | 0.1655 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
| GVS SpA | 357.59m | 17.29m | 981.41m | 4.39k | 58.66 | 3.35 | 17.82 | 2.74 | 0.1135 | 0.1135 | 2.38 | 1.99 | 0.4201 | 1.95 | 6.20 | 96,823.30 | 2.03 | 7.35 | 2.50 | 10.82 | 53.92 | 58.74 | 4.84 | 12.44 | 1.19 | 3.87 | 0.5709 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
| Oxford Nanopore Technologies PLC | 169.67m | -154.51m | 1.05bn | 1.24k | -- | 1.61 | -- | 6.20 | -0.1851 | -0.1851 | 0.2035 | 0.7493 | 0.212 | 0.8369 | 2.73 | 137,050.10 | -19.30 | -21.12 | -21.93 | -24.67 | 53.33 | 53.90 | -91.06 | -81.85 | 3.87 | -- | 0.0608 | -- | -14.57 | 39.15 | -69.74 | -- | 8.92 | -- |
| Biotage AB | 149.75m | 18.03m | 1.09bn | 667.00 | 60.54 | 3.99 | 35.25 | 7.28 | 3.12 | 3.12 | 25.93 | 47.36 | 0.4217 | 1.70 | 6.57 | 3,080,119.00 | 5.08 | 10.74 | 5.87 | 12.77 | 62.72 | 61.34 | 12.04 | 15.77 | 1.14 | 8.71 | 0.0628 | 40.11 | 18.90 | 15.37 | -8.21 | 7.97 | 14.05 | 1.30 |
| Xvivo Perfusion AB | 50.40m | 8.71m | 1.20bn | 152.00 | 133.53 | 8.20 | 87.62 | 23.76 | 3.95 | 3.95 | 22.69 | 64.28 | 0.3441 | 1.22 | 4.48 | 4,367,031.00 | 5.95 | 1.24 | 6.45 | 1.33 | 74.16 | 73.14 | 17.28 | 4.76 | 3.27 | -- | 0.0133 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
| Embla Medical hf | 621.82m | 44.01m | 1.41bn | 4.00k | 32.02 | 2.50 | 16.90 | 2.27 | 0.9142 | 0.9142 | 12.90 | 11.73 | 0.5582 | 2.20 | 6.60 | 1,377,907.00 | 3.96 | 4.06 | 4.68 | 4.76 | 61.41 | 62.47 | 7.09 | 6.91 | 1.07 | 5.81 | 0.4325 | 3.99 | 9.33 | 5.09 | 37.34 | -6.05 | 6.50 | -- |
| SKAN Group AG | 278.10m | 22.87m | 1.49bn | 1.39k | 65.41 | 10.14 | 42.58 | 5.36 | 1.17 | 1.17 | 14.23 | 7.53 | 0.8402 | 0.7026 | 12.19 | 230,562.00 | 7.32 | 7.56 | 15.16 | 14.95 | 75.17 | 73.24 | 8.72 | 9.63 | 0.781 | 7.61 | 0.0355 | 24.09 | 15.55 | 118.77 | 38.59 | 35.49 | -- | -- |
Data as of Jul 23 2024. Currency figures normalised to Oxford Nanopore Technologies PLC's reporting currency: UK Pound GBX
26.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 11 May 2023 | 41.71m | 4.77% |
| Storebrand Asset Management ASas of 01 Jul 2024 | 35.29m | 4.04% |
| Invesco Advisers, Inc.as of 28 Feb 2023 | 28.66m | 3.28% |
| Lansdowne Partners (UK) LLPas of 28 Feb 2023 | 28.00m | 3.20% |
| GIC Pte Ltd. (Investment Management)as of 27 Mar 2024 | 25.70m | 2.94% |
| Redmile Group LLCas of 28 Feb 2023 | 24.70m | 2.83% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 01 Jul 2024 | 17.17m | 1.97% |
| The Vanguard Group, Inc.as of 01 Jul 2024 | 13.12m | 1.50% |
| Aberforth Partners LLPas of 01 Jul 2024 | 11.13m | 1.27% |
| Norges Bank Investment Managementas of 01 Jul 2024 | 8.35m | 0.96% |
More ▼
Data from 31 Dec 2023 - 10 Jul 2024Source: FactSet Research Systems Inc.
